Predict your next investment

Biologique Recherche company logo
HEALTHCARE | Elective & Aesthetic Medicine
biologique-recherche.com

See what CB Insights has to offer

Investors Count

4

Biologique Recherche Funding, Biologique Recherche Valuation & Biologique Recherche Revenue

1 Fundings

Biologique Recherche's latest funding round was a Unattributed for on October 24, 2019.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/24/2019

Unattributed

2

Date

10/24/2019

Round

Unattributed

Amount

Investors

Valuation

Revenue

Sources

2

Biologique Recherche Investors

4 Investors

Biologique Recherche has 4 investors. Frere-Bourgeois invested in Biologique Recherche's Unattributed funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/24/2019

10/24/2019

1
Unattributed

Family Office

Belgium

00/00/0000

00/00/0000

Peter Brabeck-Letmathe

Subscribe to see more

Angel Investor (Individual)

00/00/0000

00/00/0000

Van Rappard Family

Subscribe to see more

Family Office

Denmark

00/00/0000

00/00/0000

EPI

Subscribe to see more

Family Office

France

First funding

10/24/2019

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/24/2019

00/00/0000

00/00/0000

00/00/0000

Investor

Peter Brabeck-Letmathe

Van Rappard Family

EPI

Rounds

1
Unattributed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Family Office

Angel Investor (Individual)

Family Office

Family Office

Location

Belgium

Denmark

France

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.